|
565.
|
|
12 p, 1.9 MB |
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
/
Vigón, Lorena (Instituto de Salud Carlos III) ;
Vázquez-Morón, Sonia (Instituto de Salud Carlos III) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
González-García, Juan (Hospital Universitario La Paz (Madrid)) ;
Jiménez-Sousa, Ma Ángeles (Instituto de Salud Carlos III) ;
Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdia Sant Pau) ;
Crespo Casal, Manuel (Hospital Álvaro Cunqueiro (Vigo)) ;
de los Santos, Ignacio (Hospital Universitario de la Princesa (Madrid)) ;
Von Wichmann, Miguel A. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Carrero, Ana (Hospital General Universitario Gregorio Marañón) ;
Yélamos, María Belén (Universidad Complutense de Madrid) ;
Gómez, Julián (Universidad Complutense de Madrid) ;
Resino, Salvador (Instituto de Salud Carlos III) ;
Martínez, Isidoro (Instituto de Salud Carlos III) ;
Miralles, P. (Hospital General Universitario Gregorio Marañón) ;
López, J.C. (Hospital General Universitario Gregorio Marañón) ;
Parras, F. (Hospital General Universitario Gregorio Marañón) ;
Padilla, B. (Hospital General Universitario Gregorio Marañón) ;
Aldamiz-Echevarría, T. (Hospital General Universitario Gregorio Marañón) ;
Tejerina, F. (Hospital General Universitario Gregorio Marañón) ;
Díez, C. (Hospital General Universitario Gregorio Marañón) ;
Pérez-Latorre, L. (Hospital General Universitario Gregorio Marañón) ;
Fanciulli, C. (Hospital General Universitario Gregorio Marañón) ;
Gutiérrez, I. (Hospital General Universitario Gregorio Marañón) ;
Ramírez, M. (Hospital General Universitario Gregorio Marañón) ;
Carretero, S. (Hospital General Universitario Gregorio Marañón) ;
Bellón, J.M. (Hospital General Universitario Gregorio Marañón) ;
Bermejo, Javier (Hospital General Universitario Gregorio Marañón) ;
Hontañón, V. (Hospital Universitario La Paz (Madrid)) ;
Arribas, Jose (Hospital Universitario La Paz (Madrid)) ;
Montes, M.L. (Hospital Universitario La Paz (Madrid)) ;
Bernardino, I. (Hospital Universitario La Paz (Madrid)) ;
Pascual, J.F. (Hospital Universitario La Paz (Madrid)) ;
Zamora, F. (Hospital Universitario La Paz (Madrid)) ;
Peña, J.M. (Hospital Universitario La Paz (Madrid)) ;
Arnalich, F. (Hospital Universitario La Paz (Madrid)) ;
Díaz, M. (Hospital Universitario La Paz (Madrid)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Sanz, J. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Bustinduy, M.J. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Iribarren, J.A. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Rodríguez-Arrondo, F. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Eynde, E.Van den (Hospital Universitari Vall d'Hebron) ;
Pérez, M. (Hospital Universitari Vall d'Hebron) ;
Ribera, E. (Hospital Universitari Vall d'Hebron) ;
Casado, José Luis (Hospital Universitario Ramón y Cajal (Madrid)) ;
Dronda, F. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Moreno, A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Pérez-Elías, M.J. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Sanfrutos, M.A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Moreno, S. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Quereda, C. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Arranz, A. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Casas, E. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Miguel, J.de (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Schroeder, S. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Vergas, J. (Hospital Clínico San Carlos (Madrid)) ;
Téllez, M.J. (Hospital Clínico San Carlos (Madrid)) ;
Vinuesa, D. (Hospital Universitario San Cecilio (Granada)) ;
Muñoz, L. (Hospital Universitario San Cecilio (Granada)) ;
Hernández-Quero, J. (Hospital Universitario San Cecilio (Granada)) ;
Ferrer, A. (Hospital Clínico Universitario) ;
Galindo, M.J. (Hospital Clínico Universitario) ;
Ortiz, L. (Hospital General Universitario) ;
Ortega, E. (Hospital General Universitario) ;
Montero, M. (Hospital Universitari La Fe) ;
Blanes, M. (Hospital Universitari La Fe) ;
Cuellar, S. (Hospital Universitari La Fe) ;
Lacruz, J. (Hospital Universitari La Fe) ;
Salavert, M. (Hospital Universitari La Fe) ;
López-Aldeguer, J. (Hospital Universitari La Fe) ;
Pérez, G. (Hospital Universitario de Getafe (Madrid)) ;
Gaspar, G. (Hospital Universitario de Getafe (Madrid)) ;
Yllescas, M. (Fundación SEIMC-GESIDA) ;
Crespo, P. (Fundación SEIMC-GESIDA) ;
Aznar, E. (Fundación SEIMC-GESIDA) ;
Esteban, H. (Fundación SEIMC-GESIDA) ;
Universitat Autònoma de Barcelona
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. [...]
2019 -  10.1038/s41598-019-48592-5
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 12163
|
|
|
566.
|
|
7 p, 227.7 KB |
Delayed antibiotic prescribing for respiratory tract infections : Protocol of an individual patient data meta-analysis
/
Stuart, Beth (University of Southampton) ;
Hounkpatin, Hilda (University of Southampton) ;
Becque, Taeko (University of Southampton) ;
Yao, Guiqing (University of Leicester) ;
Zhu, Shihua (University of Southampton) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Altiner, Attila (University of Rostock) ;
Arroll, Bruce (University of Auckland) ;
Böhning, Dankmar (University of Southampton) ;
Bostock, Jennifer (King's College London) ;
Bucher, Heiner (University of Basel) ;
De La Poza, Mariam (Institut Català de la Salut) ;
Francis, Nick A. (Cardiff University) ;
Gillespie, David (Cardiff University) ;
Hay, Alastair D. (University of Bristol) ;
Kenealy, Timothy (University of Auckland) ;
Löffler, Christin (Rostock University Medical Center) ;
Mas Dalmau, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz, Laura (Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)) ;
Samuel, Kirsty (University of Leeds) ;
Moore, Michael (University of Southampton) ;
Little, Paul (University of Southampton) ;
Universitat Autònoma de Barcelona
Delayed prescribing can be a useful strategy to reduce antibiotic prescribing, but it is not clear for whom delayed prescribing might be effective. This protocol outlines an individual patient data (IPD) meta-analysis of randomised controlled trials (RCTs) and observational cohort studies to explore the overall effect of delayed prescribing and identify key patient characteristics that are associated with efficacy of delayed prescribing. [...]
2019 - 10.1136/bmjopen-2018-026925
BMJ open, Vol. 9 Núm. 1 (january 2019) , p. e026925
|
|
|
567.
|
|
9 p, 627.4 KB |
Effects of alirocumab on types of myocardial infarction : Insights from the ODYSSEY OUTCOMES trial
/
White, Harvey D. (Auckland City Hospital) ;
Gabriel Steg, P. (Royal Brompton Hospital (Londres)) ;
Szarek, Michael (SUNY Downstate Medical Center School of Public Health) ;
Bhatt, Deepak L (Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Erglis, Andrejs (University of Latvia) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Department of Medicine) ;
Wouter Jukema, J. (Leiden University Medical Center) ;
Lopes, Renato D. (Duke Clinical Research Institute) ;
Mahaffey, Kenneth W. (Stanford University School of Medicine) ;
Moryusef, Angele (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals) ;
Roe, Matthew T. (Duke Clinical Research Institute) ;
Sritara, Piyamitr (Mahidol University) ;
Tricoci, Pierluigi (CSL Behring) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Cequier Fillat, Angel R. (Hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. [...]
2019 - 10.1093/eurheartj/ehz299
European heart journal, Vol. 40 Núm. 33 (january 2019) , p. 2801-2809
|
|
|
568.
|
|
7 p, 440.7 KB |
Effectiveness of a parent-training program in Spain : reducing the Southern European evaluation gap Efectividad de un programa de educación parental en España: reducir la brecha en cuanto a evaluación en el sur de Europa
/
Vázquez, Noelia (Universitat de Barcelona) ;
Molina, M.Cruz (Agència de Salut Pública de Barcelona) ;
Ramos, Pilar (Agència de Salut Pública de Barcelona) ;
Artazcoz, Lucía 1963- (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
We implemented and evaluated the Parenting Skills Program for families in Spain 1) to examine differences in parenting skills, social support, children's behaviours and parental stress pre, immediately post and six months post intervention and 2) to identify mechanisms by which the intervention is related to changes in the four outcomes examined. [...]
2019 - 10.1016/j.gaceta.2017.06.005
Gaceta sanitaria, Vol. 33 Núm. 1 (enero 2019) , p. 10-16
|
|
|
569.
|
|
13 p, 965.1 KB |
Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
/
Tack, Jan (University of Leuven) ;
Stanghellini, Vincenzo (University Hospital S.Orsola) ;
Mearin, Fermín 1956- (Centro Médico Teknon) ;
Yiannakou, Yan (County Durham and Darlington NHS Trust) ;
Layer, Peter (Israelitic Hospital) ;
Coffin, Benoit (Paris Diderot University) ;
Simren, Magnus (Sahlgrenska University Hospital (Suècia)) ;
Mackinnon, Jonathan (TFS Develop S.L) ;
Wiseman, Gwen (Allergan International) ;
Marciniak, Anne (Allergan International) ;
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Irritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK). [...]
2019 - 10.1186/s12876-019-0985-1
BMC Gastroenterology, Vol. 19 Núm. 1 (july 2019) , p. 69
|
|
|
570.
|
|
13 p, 828.8 KB |
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
/
Villatoro, Sergi (Grup Quirónsalud (Barcelona, Catalunya)) ;
Mayo-de-las-Casas, Clara (Grup Quirónsalud (Barcelona, Catalunya)) ;
Jordana-Ariza, Núria (Grup Quirónsalud (Barcelona, Catalunya)) ;
Viteri-Ramírez, Santiago (Grup Quirónsalud (Barcelona, Catalunya)) ;
Garzón-Ibañez, Mónica (Grup Quirónsalud (Barcelona, Catalunya)) ;
Moya-Horno, Irene (Hospital General de Catalunya) ;
García-Peláez, Beatrtiz (Grup Quirónsalud (Barcelona, Catalunya)) ;
González-Cao, María (Grup Quirónsalud (Barcelona, Catalunya)) ;
Malapelle, Umberto (University of Naples Federico II) ;
Balada-Bel, Ariadna (Grup Quirónsalud (Barcelona, Catalunya)) ;
Martínez-Bueno, Alejandro (Grup Quirónsalud (Barcelona, Catalunya)) ;
Campos, Raquel (Grup Quirónsalud (Barcelona, Catalunya)) ;
Reguart, Noemi (Hospital Clínic i Provincial de Barcelona) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Blanco, Remei (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Blasco, Ana (Hospital General Universitari de València) ;
Catalán, María J. (Grup Quirónsalud (Barcelona, Catalunya)) ;
González, Xavier (Hospital General de Catalunya) ;
Troncone, Giancarlo (University of Naples Federico II) ;
Karachaliou, Niki (Hospital del Sagrat Cor (Barcelona, Catalunya)) ;
Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Molina-Vila, Miguel Ángel (Grup Quirónsalud (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Many advanced cases of cancer show central nervous system, pleural, or peritoneal involvement. In this study, we prospectively analyzed if cerebrospinal fluid (CSF), pleural effusion (PE), and/or ascites (ASC) can be used to detect driver mutations and guide treatment decisions. [...]
2019 - 10.1002/1878-0261.12574
Molecular Oncology, Vol. 13 Núm. 12 (january 2019) , p. 2633-2645
|
|
|
571.
|
|
12 p, 1.2 MB |
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease
/
Startin, Carla M. (LonDownS Consortium (London Down Syndrome Consortium)) ;
Ashton, Nicholas J. (University of Gothenburg) ;
Hamburg, Sarah (LonDownS Consortium (London Down Syndrome Consortium)) ;
Hithersay, Rosalyn (LonDownS Consortium (London Down Syndrome Consortium)) ;
Wiseman, Frances K. (University College London) ;
Mok, Kin Y. (Hong Kong University of Science and Technology) ;
Hardy, John (University College London) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Lovestone, Simon (University of Oxford) ;
Parnetti, Lucilla (University of Perugia) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Hye, Abdul (Maudsley NHS Foundation) ;
Fisher, Elisabeth ;
Nizetic, Dean ;
Tybulewicz, Victor ;
Karmiloff-Smith, Anette ;
Al-Janabi, Tamara ;
Zhang, David ;
Strydom, André (LonDownS Consortium (London Down Syndrome Consortium)) ;
Universitat Autònoma de Barcelona
Down syndrome (DS), caused by chromosome 21 trisomy, is associated with an ultra-high risk of dementia due to Alzheimer's disease (AD), driven by amyloid precursor protein (APP) gene triplication. Understanding relevant molecular differences between those with DS, those with sporadic AD (sAD) without DS, and controls will aid in understanding AD development in DS. [...]
2019 - 10.1186/s13195-019-0477-0
Alzheimer's research & therapy, Vol. 11 Núm. 1 (21 2019) , p. 26
|
|
|
572.
|
|
6 p, 731.5 KB |
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood : Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
/
Stamate, Daniel (University of London) ;
Kim, Min (Steno Diabetes Center Copenhagen) ;
Proitsi, Petroula (King's College London) ;
Westwood, Sarah (University of Oxford) ;
Baird, Alison (University of Oxford) ;
Nevado-Holgado, Alejo (University of Oxford) ;
Hye, Abdul (King's College London) ;
Bos, Isabelle (Amsterdam UMC) ;
Vos, Stephanie J.B. (Maastricht University) ;
Vandenberghe, Rik (Amsterdam UMC) ;
Teunissen, Charlotte E. (Amsterdam UMC. University Medical Center) ;
Kate, Mara Ten (Amsterdam UMC. University Medical Center) ;
Scheltens, Philip (Vrije Universiteit Amsterdam) ;
Gabel, Silvy (Laboratory for Cognitive Neurology) ;
Meersmans, Karen (Laboratory for Cognitive Neurology) ;
Blin, Olivier (Aix-Marseille Université) ;
Richardson, Jill (GlaxoSmithKline R&D) ;
De Roeck, Ellen (University of Antwerp) ;
Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ;
Sleegers, Kristel (Center for Molecular Neurology. VIB) ;
Bordet, Régis (University of Lille) ;
Ramit, Lorena (Hospital Clínic i Provincial de Barcelona) ;
Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ;
Tsolaki, Magda (AHEPA University Hospital (Grècia)) ;
Verhey, Frans (Maastricht University) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Peyratout, Gwendoline (Lausanne University Hospital) ;
Tainta, Mikel (Fundacion CITA-alzheimer Fundazioa) ;
Johannsen, Peter (Copenhagen University Hospital) ;
Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ;
Frölich, Lutz (University of Heidelberg) ;
Dobricic, Valerija (University of Lübeck) ;
Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ;
Molinuevo, José Luis (Universitat Pompeu Fabra) ;
Wallin, Anders (Sahlgrenska Academy at the University of Gothenburg) ;
Popp, Julius (Geneva University Hospitals) ;
Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ;
Bertram, Lars (University of Oslo) ;
Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Streffer, Johannes (University of Antwerp) ;
Visser, Pieter J. (Amsterdam UMC) ;
Lovestone, Simon (Janssen-Cilag UK Ltd) ;
Legido-Quigley, Cristina (King's College London) ;
Universitat Autònoma de Barcelona
Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers. [...]
2019 - 10.1016/j.trci.2019.11.001
Alzheimer's & dementia, Vol. 5 (2019) , p. 933-938
|
|
|
573.
|
|
4 p, 197.4 KB |
Health effects of desert dust and sand storms : A systematic review and meta-analysis protocol
/
Tobias, Aurelio (Institut d'Avaluació Ambiental i Investigació de l'Aigua (IDAEA)) ;
Karanasiou, Angeliki (Institut d'Avaluació Ambiental i Investigació de l'Aigua (IDAEA)) ;
Amato, Fulvio (Institut d'Avaluació Ambiental i Investigació de l'Aigua (IDAEA)) ;
Roqué i Figuls, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Querol, Xavier (Institut d'Avaluació Ambiental i Investigació de l'Aigua (IDAEA)) ;
Universitat Autònoma de Barcelona
Desert dust concentrations raise concerns about adverse effects on human health. During the last decade, special attention has been given to mineral dust particles from desert dust and sand storms. However, evidence from previous reviews reported inconclusive results on their health effects and the biological mechanism remains unclear. [...]
2019 - 10.1136/bmjopen-2019-029876
BMJ open, Vol. 9 Núm. 7 (january 2019) , p. e029876
|
|
|
574.
|
|
12 p, 2.1 MB |
Association of platelet binding to lymphocytes with B cell abnormalities and clinical manifestations in systemic lupus erythematosus
/
Zamora, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Toniolo, Elide (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Díaz Torne, César (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Cantó, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ;
Magallares López, Berta Paula (Institut d'Investigació Biomèdica Sant Pau) ;
Ortiz, M. Àngels (Institut d'Investigació Biomèdica Sant Pau) ;
Perea, Lidia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Corominas, Hèctor (Institut d'Investigació Biomèdica Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Systemic lupus erythematosus (SLE) is an autoimmune disease associated with the polyclonal activation of B lymphocytes and the production of autoantibodies that cause immune complex-related inflammation. [...]
2019 - 10.1155/2019/2473164
Mediators of Inflammation, Vol. 2019 (2019) , p. 2473164
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
